ClinicalTrials.Veeva
Menu

Find clinical trials for Pancreatic Cancer in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Adenocarcinoma
Cancer
Carcinoma
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer
Squamous Cell Carcinoma of Head and Neck

Pancreatic Cancer trials near Kansas City, KS, USA:

Niraparib in Metastatic Pancreatic Cancer After Previous Chemotherapy (NIRA-PANC): a Phase 2 Trial

The goal of this clinical research study is to learn if Niraparib can help to control metastatic pancreatic cancer. The safety of t...

Active, not recruiting
Pancreatic Cancer
Drug: Niraparib Treatment

Phase 2

University of Kansas
University of Kansas

Kansas City, Kansas, United States and 5 other locations

open label, multi-center, clinical study of Chimeric Antigen Receptor T Cells (CAR-T) targeting claudin18.2 in patients with advanced gastric, pancreatic...

Active, not recruiting
Gastric Cancer
Pancreatic Cancer
Biological: CT041

Phase 1, Phase 2

CARsgen Therapeutics

Kansas City, Kansas, United States and 15 other locations

Researchers want to discover if the new drug "TG01" will work with participants' bodies to help their immune system attack any cancer cells ...

Active, not recruiting
Pancreas Cancer
Biological: TG01 Vaccine
Drug: QS-21

Phase 2

University of Kansas
University of Kansas

Kansas City, Missouri, United States and 4 other locations

stomach cancer, gastroesophageal junction cancer, (GEJ cancer) or pancreatic cancer. GEJ is where the t...

Enrolling
Pancreatic Adenocarcinoma
Gastroesophageal Junction (GEJ) Adenocarcinoma
Drug: ASP2138
Drug: Irinotecan

Phase 1

Astellas
Astellas

Westwood, Kansas, United States and 32 other locations

This trial will study tisotumab vedotin to find out whether it is an effective treatment alone or with other anticancer drugs for certain solid tumors...

Enrolling
Exocrine Pancreatic Cancer
Colorectal Neoplasms
Drug: cisplatin
Drug: carboplatin

Phase 2

Seagen
Seagen

Fairway, Kansas, United States and 71 other locations

and efficacy of 9-ING-41, a potent GSK-3β inhibitor, as a single agent and in combination with cytotoxic agents, in patients with refractory cancers...

Active, not recruiting
Neoplasm of Lung
Neoplasms Pancreatic
Drug: Gemcitabine - 21 day cycle
Drug: 9-ING-41

Phase 2

Actuate Therapeutics

Kansas City, Kansas, United States and 65 other locations

This is a phase 1 first in human, dose escalation trial of GP-2250 administered in combination with gemcitabine in subjects with advanced pancreatic...

Enrolling
Pancreatic Cancer, Adult
Drug: GP-2250

Phase 1

Geistlich Pharma

Fairway, Kansas, United States and 4 other locations

of care. It is being tested against advanced and/or metastatic solid tumors including gastric, gastroesophageal junction, pancreatic...

Enrolling
Advanced Cancer
Gastric Cancer
Drug: mFOLFOX6
Drug: Gemcitabine

Phase 1, Phase 2

Transcenta

Kansas City, Kansas, United States and 18 other locations

as PK and pharmacodynamics of XL309 (previously ISM3091) administered alone or in combination with olaparib in subjects with advanced solid tumors...

Enrolling
Advanced Solid Tumor
Drug: Olaparib
Drug: XL309 (ISM3091)

Phase 1

Exelixis
Exelixis

Kansas City, Missouri, United States and 11 other locations

A Phase 1 Dose Escalation and Expansion Study of IMP7068 Monotherapy in Advanced Solid Tumors...

Enrolling
Advanced Solid Tumors
Drug: IMP7068

Phase 1

IMPACT Therapeutics

Fairway, Kansas, United States and 15 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems